<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the nutritional status, and provide evidence for nutritional treatment option </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A total of 452 patients with <z:e sem="disease" ids="C0685938" disease_type="Neoplastic Process" abbrv="">gastrointestinal cancer</z:e> were selected, including 156 <z:hpo ids='HP_0012126'>gastric cancer</z:hpo>,117 <z:hpo ids='HP_0003003'>colon cancer</z:hpo>, and 180 rectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The nutritional risk screening 2002(NRS2002) was applied to grade the nutritional risk </plain></SENT>
<SENT sid="3" pm="."><plain>A multi-frequency bioelectrical impedance analysis was used to measure the patients' body composition </plain></SENT>
<SENT sid="4" pm="."><plain>Albumin (Alb), prealbumin(PA), transferring(Tf), <z:chebi fb="1" ids="50211">retinol</z:chebi> binding protein(RBP), red blood cell(RBC), <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> (Hb), haematocrit(Hct) were measured after fasting </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The rate of patients with NRS2002 score more than 3 was 70.5%(110/156) for <z:hpo ids='HP_0012126'>gastric cancer</z:hpo>, 53.8%(63/117) for <z:hpo ids='HP_0003003'>colon cancer</z:hpo>, and 46.7%(86/180) for <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The score for impaired nutritional status more than 1 for <z:hpo ids='HP_0012126'>gastric cancer</z:hpo> was higher than that for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>(P&lt;0.05), while patients with disease score more than 2 was less for <z:hpo ids='HP_0012126'>gastric cancer</z:hpo>(P&lt;0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>Body mass index(BMI), <z:hpo ids='HP_0001513'>obesity</z:hpo> degree, fat content, fat percentage, and arm circumference were lower in <z:hpo ids='HP_0012126'>gastric cancer</z:hpo> patients as compared to <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients(P&lt;0.05); but protein percentage, muscle percentage, ratio of muscles of arm, and cell mass percentage were higher in <z:hpo ids='HP_0012126'>gastric cancer</z:hpo> patients(P&lt;0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>The proportions of patients with low Alb, PA, Tf, BC, Hb, Hct were higher for <z:hpo ids='HP_0012126'>gastric cancer</z:hpo> and <z:hpo ids='HP_0003003'>colon cancer</z:hpo>(P&lt;0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Patients with <z:hpo ids='HP_0012126'>gastric cancer</z:hpo> are prone to fat loss and therefore have a higher nutritional risk and <z:hpo ids='HP_0004395'>malnutrition</z:hpo> than those with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Combination of body composition analysis and laboratory examination may achieve comprehensive evaluation of the nutritional status of patients, and provide the evidence of nutritional therapy by being combined with NRS2002 score </plain></SENT>
</text></document>